Nao Nakamura

Screening of Fabry disease in patients with chronic kidney disease in Japan

Ryo Shibata, K. Fukami, H. Sakuraba, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations

Y. Koda, Ryo Shibata, K. Fukami, 2020, Clinical and Experimental Nephrology.

Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia

S. Yamagishi, K. Fukami, Yuka Kurokawa, 2018, Clinical and Experimental Nephrology.

AGEs–RAGE overexpression in a patient with smoking-related idiopathic nodular glomerulosclerosis

K. Asanuma, Ryo Shibata, K. Fukami, 2018, CEN Case Reports.

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Scientific Reports.

Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study

Yusuke Suzuki, Mina Kato, Tsutomu Inoue, 2022, Journal of Nephrology.

Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial

H. Miyazaki, Ryo Shibata, K. Fukami, 2020, Renal Replacement Therapy.

Carnitine deficiency is associated with decreased exercise activity in hemodialysis patients

K. Fukami, Yuka Kurokawa, Y. Kaida, 2019, Renal Replacement Therapy.

Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review

K. Fukami, H. Sakuraba, Yuka Kurokawa, 2019, BMC nephrology.

A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry

A. Shimizu, H. Sugiyama, K. Fukami, 2022, Clinical and Experimental Nephrology.

Initiation of renin–angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study

Mina Kato, Tsutomu Inoue, S. Goto, 2023, Clinical and Experimental Nephrology.

Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

S. Yamagishi, S. Yamagishi, T. Matsui, 2015, Hormone and Metabolic Research.

Effectiveness of cryofiltration and mizoribine combination with oral steroid therapy in a patient with membranoproliferative glomerulonephritis due to essential cryoglobulinemia

S. Okuda, Ryo Shibata, K. Fukami, 2019, CEN Case Reports.

Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

S. Yamagishi, Nao Nakamura, Yuri Nishino, 2015, Hormone and Metabolic Research.